[PDF][PDF] Update of the drug resistance mutations in HIV-1: Fall 2006
VA Johnson, F Brun-Vézinet, B Clotet, DR Kuritzkes… - Top HIV Med, 2006 - iasusa.org
The International AIDS Society–USA (IAS–USA) Drug Resistance Mutations Group is
marking 6 years as an independent volunteer panel of experts focused on identifying key …
marking 6 years as an independent volunteer panel of experts focused on identifying key …
Transmission of HIV-1 drug resistance
Background: The use of highly-active anti-retroviral therapy (HAART) for treating HIV
infections is increasing. Recent studies have demonstrated that HAART is improving both …
infections is increasing. Recent studies have demonstrated that HAART is improving both …
Introduction of HIV drug-resistance testing in clinical practice
The therapeutic management of HIV-1 infection has improved significantly in the past 2
years. Diseases such as AIDS, with a prolonged asymptomatic period (up to 10 years), allow …
years. Diseases such as AIDS, with a prolonged asymptomatic period (up to 10 years), allow …
Development of antiretroviral drug resistance
MA Wainberg, GJ Zaharatos… - New England Journal of …, 2011 - Mass Medical Soc
Analysis of HIV drug resistance has identified sites on HIV target genes that convey
resistance to particular classes of agents. These data may be especially important in …
resistance to particular classes of agents. These data may be especially important in …
HIV-1 drug resistance evolution among patients on potent combination antiretroviral therapy with detectable viremia
S Napravnik, D Edwards, P Stewart… - JAIDS Journal of …, 2005 - journals.lww.com
Many patients infected with HIV do not achieve or maintain virologic suppression below
levels of detection while on potent combination antiretroviral therapy. The likelihood of …
levels of detection while on potent combination antiretroviral therapy. The likelihood of …
Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel
MS Hirsch, HF Günthard, JM Schapiro… - Clinical Infectious …, 2008 - academic.oup.com
Resistance to antiretroviral drugs remains an important limitation to successful human
immunodeficiency virus type 1 (HIV-1) therapy. Resistance testing can improve treatment …
immunodeficiency virus type 1 (HIV-1) therapy. Resistance testing can improve treatment …
Reduced antiretroviral drug susceptibility among patients with primary HIV infection
ContextThe transmission of drug-resistant human immunodeficiency virus (HIV) has been
documented, but the prevalence of such transmission is unknown. ObjectiveTo assess the …
documented, but the prevalence of such transmission is unknown. ObjectiveTo assess the …
HIV-1 drug resistance profiles in children and adults with viral load of< 50 copies/ml receiving combination therapy
M Hermankova, SC Ray, C Ruff, M Powell-Davis… - Jama, 2001 - jamanetwork.com
ContextThe continued release of human immunodeficiency virus type 1 (HIV-1) into plasma
at very low levels during highly active antiretroviral therapy (HAART) can be detected using …
at very low levels during highly active antiretroviral therapy (HAART) can be detected using …
Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial
JL Meynard, M Vray, L Morand-Joubert, E Race… - Aids, 2002 - journals.lww.com
Objective To assess the respective value of phenotype versus genotype versus standard of
care for choosing antiretroviral therapy in patients failing protease inhibitor-containing …
care for choosing antiretroviral therapy in patients failing protease inhibitor-containing …
Public health implications of antiretroviral therapy and HIV drug resistance
MA Wainberg, G Friedland - Jama, 1998 - jamanetwork.com
Widespread use of antiretroviral agents and increasing occurrence of human
immunodeficiency virus (HIV) strains resistant to these drugs have given rise to a number of …
immunodeficiency virus (HIV) strains resistant to these drugs have given rise to a number of …